NSC |
Compound |
Enrichment |
Correlation |
NSC 721045 |
Null |
0.029334167004364 |
0.34799628 |
NSC 741909 |
1H-Indole-3-methanol, 1-[(4-chlorophenyl)methyl]- |
0.029334167004364 |
0.11685627 |
NSC 757933 |
1,3-diphenyl-4-(3-phenyl-4,5-dihydro-1H-pyrazol-5-yl)-1H-pyrazole |
0.0293341670043647 |
-0.28751374 |
NSC 751902 |
2-4-[5-(3,4-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,7-dimethoxy-1,3-benzothiazole |
0.0293341670043648 |
0.41158595 |
NSC 749160 |
Null |
0.0295480456086945 |
0.68030963 |
NSC 751830 |
2-(4-hydroxypiperidin-1-yl)-4-(4-morpholinophenylamino)pyrido[4,3-d]pyrimidin-5(6H)-one |
0.0295480456086945 |
0.15326609 |
NSC 76150 |
Null |
0.0295480456086945 |
0.15385362 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0295480456086947 |
0.31142303 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.0295480456086947 |
0.26862275 |
NSC 144163 |
Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- |
0.0295480456086947 |
0.6288805 |